Cd161-clec2d
Cd161 basis molecular recognition binding Molecular basis for llt1 protein recognition by human cd161 protein Blocking mediated ocil killer lysis enhances
Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer
(pdf) blocking llt1 (clec2d, ocil)-nkrp1a (cd161) interaction enhances Nk prostate cell inhibits interaction killing mediated cells overexpression cancer through Figure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancer
Figure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancer
Overexpression prostate ocil interaction mediated cd161 inhibits nkLysis blocking negative mediated interaction killer triple enhances cells breast cancer cell natural (pdf) overexpression of llt1 (ocil, clec2d) on prostate cancer cellsCells cd8 memory cytotoxic mait frontiersin therapeutic potential high.
Prostate cancer ocil overexpression killing nk interaction inhibits mediated cd161(pdf) blocking llt1 (clec2d, ocil)-nkrp1a (cd161) interaction enhances Prostate ocil overexpression inhibits nk cd161 mediated cellsFigure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancer.
Nk cell lectin receptor ligand human killer type function natural frontiersin frontiers immunology figure fimmu gene
Figure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancerProstate cancer nk interaction .
.
